Blood Biomarker May Help Verify CT-Captured Lung Cancer
Researchers have found a blood biomarker that can complement LDCT by distinguishing NSCLC from benign nodules without an invasive biopsy.
Read MorePosted by Chris Wolski | Jul 13, 2022 | Lung Cancer |
Researchers have found a blood biomarker that can complement LDCT by distinguishing NSCLC from benign nodules without an invasive biopsy.
Read MorePosted by Andy Lundin | Jul 8, 2022 | Molecular Diagnostics |
BillionToOne announced the launch of its first oncology liquid biopsy products, Northstar Select and Northstar Response.
Read MorePosted by Andy Lundin | Jul 8, 2022 | Cancer |
A scientist working in AI for cancer research published a study detailing research that uses big data to find cancerous mutations in cells.
Read MorePosted by Andy Lundin | Jul 7, 2022 | Company News, Lung Cancer |
Medial EarlySign signed a new partnership with Roche to create innovative, evidence-based solutions for early detection of lung cancer.
Read MorePosted by Andy Lundin | Jun 21, 2022 | Cancer, Company News |
Global diagnostic laboratory company Artemis DNA closed its Houston, Texas facility to optimize the company’s strategy in California.
Read More